Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia
News-Medical · October 12, 2026
%2c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
Source:News-Medical
Comments
No comments yet.
Sign in to join the conversation.
Sign InNo comments yet.
Sign in to join the conversation.
Sign In